Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters

Language
Publication year range
1.
J. nutr. biochem ; 22(9): 849-855, Sept. 2011.
Article in English | SES-SP, SES SP - Instituto Butantan, SES-SP, SESSP-IBACERVO | ID: biblio-1063959

ABSTRACT

Short chain fatty acids (SCFAs) are fermentation products of anaerobic bacteria. More than just being an important energy source for intestinal epithelial cells, these compounds are modulators of leukocyte function and potential targets for the development of new drugs. The aim of this study was to evaluate the effectsof SCFAs (acetate, propionate and butyrate) on production of nitric oxide (NO) and proinflammatory cytokines [tumor necrosis factor á (TNF-á) and cytokineinduced neutrophil chemoattractant-2 (CINC-2áâ)] by rat neutrophils. The involvement of nuclear factor êB (NF-êB) and histone deacetylase (HDAC) wasexamined. The effect of butyrate was also investigated in vivo after oral administration of tributyrin (a pro-drug of butyrate). Propionate and butyrate diminished TNF-á, CINC-2áâ and NO production by LPS-stimulated neutrophils. We also observed that these fatty acids inhibit HDAC activity and NF-êB activation, which might be involved in the attenuation of the LPS response. Products of cyclooxygenase and 5-lipoxygenase are not involved in the effects of SCFAs as indicated by the results obtained with the inhibitors of these enzymes. The recruitment of neutrophils to the peritonium after intraperitoneal administration of a glycogen solution (1%) and the ex vivo production of cytokines and NO by neutrophils were attenuated in rats that previously received tributyrin. These results argue that this triglyceride may be effective in the treatment of inflammatory conditions.


Subject(s)
Rats , Cyclooxygenase Inhibitors/analysis , Cyclooxygenase Inhibitors/therapeutic use , Fatty Acids/analysis , Fatty Acids/isolation & purification , Fatty Acids/metabolism , Butyrates/analysis , Lipopolysaccharides/analysis , Lipopolysaccharides/therapeutic use , Neutrophils
SELECTION OF CITATIONS
SEARCH DETAIL